Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.39
-1.85%
Mkt Cap $5.95M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+669.3%
Consensus $3.00 vs current $0.39
NASDAQ·Healthcare·Biotechnology
$0.39
-1.85%
Mkt Cap $5.95M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+669.3%
Consensus $3.00 vs current $0.39